, /PRNewswire/ -- SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce the launch of the , a comprehensive, global resource facilitating informed patient decision-making via access to specialized clinical programs expert in the diagnosis and treatment of sarcoma. As the care of patients with cancer, particularly uncommon cancers such as sarcoma, becomes increasingly complex and therapeutic options become more nuanced, access to expert clinicians is more critical than ever for optimal decision making by the patients and caregivers. Sarcoma is a rare and heterogeneous group of cancers of connective tissues that comprise nearly 20% of childhood cancers and 1% of adult cancers.
Centers included in the Sarcoma Centers Registry must apply and be determined to have met qualifying criteria. With dozens of sarcoma programs already accepted, SARC invites all sarcoma programs from around the globe to apply for listing— . "In 2023 SARC celebrated two decades of fostering collaborative efforts to advance breakthroughs in sarcoma," said , President & CEO of SARC, "and the Sarcoma Centers Registry was developed to serve as tool to help enable sarcoma patients access to more accurate and timely diagnoses and treatments, while complementing our scientific research initiatives.
" For more information, please email , or call 1-734-930-7600, extension 3. SARC (Sarcoma Alliance for Research Through Collaboration) is a US-based, non-profit (501(c)(3)) sarcoma research c.
